FDA 483 - Zoetis, LLC - January 10, 2020

An FDA inspection of Zoetis, LLC in Salisbury, MD, an animal drug manufacturer, revealed deficiencies in the handling of drug components for Type A medicated articles. Specifically, observations included inadequate measures to prevent cross-contamination during raw material sampling and a failure to follow and update written sampling procedures. These issues indicate a risk to product integrity and compliance with good manufacturing practices.